Around one-third of our 90,000 employees are either French or German. The individual teams from Rh ne-Poulenc and Hoechst are everything else but French or German. An American heads the pharma team. The CFO is a Frenchman, who came from the Hoechst side. We shouldn't get hung up on cultural or national differences.
Diversity also creates many new opportunities.
Four years ago, Novartis set its sights on the life sciences concept because it believed that synergies existed between the pharmaceutical and the agricultural businesses. In the meantime, not only Novartis but also AstraZeneca have parted from the life sciences. Your assessment is right, but at the same time it's wrong because there is no binding definition of the life sciences concept. We plan to divest the Animal Nutrition business. Moreover, in the coming 12 to 18 months, we will decide whether it would be in the interests of our shareholders and employees to divest the agricultural business or not.